Abstract
Background
The purpose of this study was to look into the effects of glutathione S-transferase M1 (GSTM1) gene polymorphism on the formation of kidney calcium oxalate stones.
Methods
A total of 159 patients with kidney calcium oxalate stones were included in this study as a case group. One hundred and three healthy individuals were included in the control group. The age, gender, and levels of calcium (Ca), uric acid (UA), creatinine (Cr), and urinary creatinine (Ucr) are tracked. Peripheral blood samples are used to perform a polymerase chain reaction to identify the glutathione S-transferase (GST) gene polymorphism (PCR). A commercial kit was used in this study to measure the levels of malondialdehyde (MDA), nitric oxide (NO), total antioxidant capacity (T-AOC), and 8-hydroxydeoxyguanosine (8-OHdG) in peripheral blood.
Results
There was no difference in age or gender distribution between the case and control groups (P > 0.05). The Cr, Ucr, Ca, UA, 8-OHdG, MDA, NO, and T-AOC in the case group were significantly higher than those in the control group (P < 0.001). The Hardy–Weinberg genetic equilibrium test showed no difference between the case group (P = 0.23) and the control group (P = 0.09). In the case group, the 8-OHdG and NO in GSTM1 null genotype were significantly higher than those in GSTM1 genotype (P < 0.05), but there was no significant difference in MDA and T-AOC (P > 0.05). Multivariate regression analysis showed that the GSTM1 null genotype was positively correlated with 8-OHdG (P < 0.001) and NO (P < 0.001).
Conclusions
GSTM1 gene polymorphism might be a detecting risk factor for kidney calcium oxalate stone formation.
Trial registration
ChiCTR2100051300.
Similar content being viewed by others
Data availability
This article contains all of the data generated or analyzed during this investigation.
References
Yasui T, Okada A, Hamamoto S, Ando R, Taguchi K, Tozawa K et al (2017) Pathophysiology-based treatment of urolithiasis. Int J Urol 24(1):32–38. https://doi.org/10.1111/iju.13187
Wigner P, Grebowski R, Bijak M, Szemraj J, Saluk-Bijak J (2021) The molecular aspect of nephrolithiasis development. Cells. https://doi.org/10.3390/cells10081926
Khan SR (2014) Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol 3(3):256–276. https://doi.org/10.3978/j.issn.2223-4683.2014.06.04
Bird VY, Khan SR (2017) How do stones form? Is unification of theories on stone formation possible? Arch Esp Urol 70(1):12–27
Thamilselvan S, Byer KJ, Hackett RL, Khan SR (2000) Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to llc-pk1 and mdck cells. J Urol 164(1):224–229
Zhai W, Zheng J, Yao X, Peng B, Liu M, Huang J et al (2013) Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in nrk-52e cells and the ethylene glycol induced renal stone formation in rat. BMC Complement Altern Med 13:228. https://doi.org/10.1186/1472-6882-13-228
Song Q, He Z, Li B, Liu J, Liu L, Liao W et al (2020) Melatonin inhibits oxalate-induced endoplasmic reticulum stress and apoptosis in hk-2 cells by activating the ampk pathway. Cell Cycle 19(20):2600–2610. https://doi.org/10.1080/15384101.2020.1810401
Selvam R (2002) Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30(1):35–47. https://doi.org/10.1007/s00240-001-0228-z
Acar H, Kilinc M, Guven S, Inan Z (2012) Glutathione s-transferase m1 and t1 polymorphisms in Turkish patients with varicocele. Andrologia 44(1):34–37. https://doi.org/10.1111/j.1439-0272.2010.01103.x
Simeunovic D, Odanovic N, Pljesa-Ercegovac M, Radic T, Radovanovic S, Coric V et al (2019) Glutathione transferase p1 polymorphism might be a risk determinant in heart failure. Dis Markers 2019:6984845. https://doi.org/10.1155/2019/6984845
Cao T, Xu N, Wang Z, Liu H (2017) Effects of glutathione s-transferase gene polymorphisms and antioxidant capacity per unit albumin on the pathogenesis of chronic obstructive pulmonary disease. Oxid Med Cell Longev 2017:6232397. https://doi.org/10.1155/2017/6232397
Buchard A, Sanchez JJ, Dalhoff K, Morling N (2007) Multiplex pcr detection of gstm1, gstt1, and gstp1 gene variants: simultaneously detecting gstm1 and gstt1 gene copy number and the allelic status of the gstp1 ile105val genetic variant. J Mol Diagn 9(5):612–617. https://doi.org/10.2353/jmoldx.2007.070030
Strange RC, Jones PW, Fryer AA (2000) Glutathione s-transferase: genetics and role in toxicology. Toxicol Lett 112–113:357–363. https://doi.org/10.1016/s0378-4274(99)00230-1
Le TH (2021) Gstm1 gene, diet, and kidney disease: implication for precision medicine?: Recent advances in hypertension. Hypertension 78(4):936–945. https://doi.org/10.1161/HYPERTENSIONAHA.121.16510
Gigliotti JC, Tin A, Pourafshar S, Cechova S, Wang YT, Sung SJ et al (2020) Gstm1 deletion exaggerates kidney injury in experimental mouse models and confers the protective effect of cruciferous vegetables in mice and humans. J Am Soc Nephrol 31(1):102–116. https://doi.org/10.1681/ASN.2019050449
Liu D, Che B, Chen P, He J, Mu Y, Chen K et al (2022) Gstt1, an increased risk factor for prostate cancer in patients with metabolic syndrome. J Clin Lab Anal 36(4):e24352. https://doi.org/10.1002/jcla.24352
Ferraro PM, Bargagli M, Trinchieri A, Gambaro G (2020) Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian-vegan diets. Nutrients. https://doi.org/10.3390/nu12030779
Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S et al (2016) Kidney stones. Nat Rev Dis Primers 2:16008. https://doi.org/10.1038/nrdp.2016.8
Yasui T, Iguchi M, Suzuki S, Kohri K (2008) Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71(2):209–213. https://doi.org/10.1016/j.urology.2007.09.034
Niimi K, Yasui T, Okada A, Hirose Y, Kubota Y, Umemoto Y et al (2014) Novel effect of the inhibitor of mitochondrial cyclophilin d activation, n-methyl-4-isoleucine cyclosporin, on renal calcium crystallization. Int J Urol 21(7):707–713. https://doi.org/10.1111/iju.12425
Ma MC, Chen YS, Huang HS (2014) Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage. Urology 83(2):510–519. https://doi.org/10.1016/j.urology.2013.09.050
Williams J, Holmes RP, Assimos DG, Mitchell T (2016) Monocyte mitochondrial function in calcium oxalate stone formers. Urology 93:221–224. https://doi.org/10.1016/j.urology.2016.03.004
Tavasoli S, Taheri M (2019) Vitamin d and calcium kidney stones: a review and a proposal. Int Urol Nephrol 51(1):101–111. https://doi.org/10.1007/s11255-018-1965-z
de Oliveira M, Mallmann NH, de Souza G, de Jesus BT, Lima ES, de Lima D et al (2021) Glutathione s-transferase, catalase, and mitochondrial superoxide dismutase gene polymorphisms modulate redox potential in systemic lupus erythematosus patients from Manaus, Amazonas. Brazil Clin Rheumatol 40(9):3639–3649. https://doi.org/10.1007/s10067-021-05680-0
Sies H (2021) Oxidative eustress: on constant alert for redox homeostasis. Redox Biol 41:101867. https://doi.org/10.1016/j.redox.2021.101867
Ceban E, Banov P, Galescu A, Botnari V (2016) Oxidative stress and antioxidant status in patients with complicated urolithiasis. J Med Life 9(3):259–262
Owens L, Laing IA, Murdzoska J, Zhang G, Turner SW, Le Souef PN (2019) Glutathione s-transferase genotype protects against in utero tobacco-linked lung function deficits. Am J Respir Crit Care Med 200(4):462–470. https://doi.org/10.1164/rccm.201807-1332OC
Kalaiselvi P, Udayapriya KL, Selvam R (1999) Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization. BJU Int 83(9):919–923. https://doi.org/10.1046/j.1464-410x.1999.00084.x
Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA (2022) Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment. Int J Mol Sci. https://doi.org/10.3390/ijms23063188
Ermak G, Davies KJ (2002) Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 38(10):713–721. https://doi.org/10.1016/s0161-5890(01)00108-0
Acknowledgements
The author thanks all the research participants in this study.
Funding
This research was funded by the Guizhou Health Commission’s Science and Technology Fund Project (gzwkj2021-211) and the Doctoral Fund of the Affiliated Hospital of Guiyang Medical College, Guizhou Province, China (C-2012-6).
Author information
Authors and Affiliations
Contributions
KT conceived and designed the experiments; PC, JC, SX, TH, ML, WL, and YY performed the experiments; PC and SX analyzed the data; SX wrote the paper; and BC and WZ participated in the discussion.
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest declared by the authors.
Ethical statement
This research involved human participants, and all the participants provided written informed consent. This research was approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University, and all work has been carried out in compliance with the Helsinki Declaration.
Research involving human participants and/or animals
The subjects in this study were all humans, and they all gave written informed consent. The Ethics Committee of Guizhou Medical University’s Affiliated Hospital gave its approval to this study (trial registration number: ChiCTR-IPR-14005580). Furthermore, every work was completed in accordance with the Helsinki Declaration.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tang, K., Xu, S., Chen, P. et al. Potential role of glutathione S‑transferase M1 gene polymorphism in kidney calcium oxalate stone formation. Int Urol Nephrol 56, 887–892 (2024). https://doi.org/10.1007/s11255-023-03846-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-023-03846-0